Literature DB >> 14962098

Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor.

Marilyn Magazin1, Ewa Poszepczynska-Guigné, Martine Bagot, Laurence Boumsell, Christelle Pruvost, Pascale Chalon, Jean-Michel Culouscou, Pascual Ferrara, Armand Bensussan.   

Abstract

Circulating malignant Sezary cells are a clonal proliferation of CD4+CD45RO+ T lymphocytes primarily involving the skin. To study the biology of these malignant T lymphocytes, we tested their ability to migrate in chemotaxis assays. Previously, we had shown that the neuropeptide neurotensin (NT) binds to freshly isolated Sezary malignant cells and induces through NT1 receptors the cell migration of the cutaneous T cell lymphoma cell line Cou-L. Here, we report that peripheral blood Sezary cells as well as the Sezary cell line Pno fail to migrate in response to neurotensin although they are capable of migrating to the chemokine stromal-cell-derived factor 1 alpha. This is in contrast with normal circulating CD4+ or CD8+ lymphocytes, which respond to both types of chemoattractants except after ex vivo short-time anti-CD3 monoclonal antibody activation, which abrogates the neurotensin-induced lymphocyte migration. Furthermore, we demonstrate that neurotensin-responsive T lymphocytes express the functional NT1 receptor responsible for chemotaxis. In these cells, but not in Sezary cells, neurotensin induces recruitment of phosphatidylinositol-3 kinase, and redistribution of phosphorylated cytoplasmic tyrosine kinase focal adhesion kinase and filamentous actin. Taken together, these results, which show functional distinctions between normal circulating lymphocytes and Sezary syndrome cells, contribute to further understanding of the physiopathology of these atypical cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962098     DOI: 10.1046/j.0022-202X.2003.22131.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.

Authors:  John Soltys; Julia Knight; Eugene Scharf; David Pitt; Yang Mao-Draayer
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

2.  Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma.

Authors:  Daheng Yang; Xianwei Zhang; Zheqian Li; Fei Xu; Chenjie Tang; Hongbing Chen
Journal:  PeerJ       Date:  2021-06-01       Impact factor: 2.984

3.  Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.

Authors:  A Abbaci; H Talbot; S Saada; N Gachard; J Abraham; A Jaccard; D Bordessoule; A L Fauchais; T Naves; M O Jauberteau
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.